CONTENTS Case Reports • V Pediatric Inflammatory Multisystem Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

CONTENTS Case Reports • V Pediatric Inflammatory Multisystem Syndrome ISSN: 2349-6592 E-ISSN: 2455-7099 Vol. No. 7 Issue No. 5 SEPTEMBER-OCTOBER 2020 Journal of Pediatric Critical Care CONTENTS Case Reports • V Pediatric inflammatory multisystem syndrome olume Editorials temporally associated with severe acute respiratory Candidemia in pediatric intensive care unit: A new syndrome coronavirus 2 – An emerging problem of 7 common and complicated comorbidity • Issue PICU: A case series Rakshay Shetty, et al. Bal Mukund, et al. Secondary bacterial infection in dengue fever in 4 Pertussis: Resurgence of a forgotten entity • children: A reality or illusion? July-August Mukesh Kumar Jain, et al. Pradeep Kumar Sharma A rare cause of pulmonary hemorrhage in the Necrotizing pneumonia in children: Is it rare intraoperative period anymore? Anurakti Dev Singla, et al. 2020 • Pages Govind Benakatti Acyclovir crystalluria: The utility of bedside urine Prevention is better than cure: The vital role of the routine microscopic examination clinical pharmacist in the pediatric intensive care Puneet Jain, et al. unit to prevent medication errors 159-227 Giant asymmetrically peaked T-waves in a child with Bridget Blowey, et al. raised intracranial pressure due to acute central Original Articles nervous system infection: A case report and review Candidemia in the pediatric intensive care unit in of the literature Eastern India Puneet Jain, et al. Chinmay Behera, et al. Point-of-care ultrasound in pediatric cardiac Secondary bacterial infection in dengue fever and masses: A case series associated risk factors – An observational study in Jangam Sachin S, et al. children Clinical Update Sridhurga Udayasankar, et al. Acute bronchiolitis in children Utility of a clinical pharmacist in the pediatric Kundan Mittal, et al. intensive care unit to identify and prevent medication errors Letter to Editor Ramaning Loni, et al. Carbamazepine poisoning: A narrow escape A retrospective study of etiology, clinical features, Mahmood Dhahir Al-Mendalawi management, and outcomes in children with Critical Thinking necrotizing pneumonia PICU quiz Maaz Ahmed, et al. Pradeep Kumar Sharma Review Article Book Review Quality indicators and improvement measures for pediatric intensive care units Cases in Pediatric Acute Care: Strengthening clinical decision making Farhan Shaikh Kundan Mittal www.jpcc.org.in Print ISSN: 2349-6592, E-ISSN: 2455-7099 Editorial Board Editor In Chief Managing Editor Founder Editor Dr. Kundan Mittal Dr. Vinayak Patki Dr. Praveen Khilnani (PGIMS, Rohtak) (Wanless Hospital, Miraj) (Madhukar Rainbow Hospital, New Delhi) Executive Editor Dr. Satish Deopujari Dr. Pradeepkumar Sharma (Nelson Hospital, Nagpur) (Shri Baiaj Action Hospital, New Delhi) Associate Editors Dr. Santosh Soans Dr. Arun Baranwal Dr. Atul Jindal (AJ Institute, Mangalore) (PGI, Chandigarh) (AllMS, Raipur) Dr. Vishram Buche Dr. Sasidaran K. Dr. Utpal Bhalala (Nelson Hospital, Nagpur) (Mehta Children Hospital, Chennai) (Baylor College of Medicine, USA) Dr. Manindar Dhaliwal (Medanta, Gurgaon) Senior Editors Dr. (Prof) Sunit Singhi Dr. Karunakara BP Dr. Basavaraja GV (Medanta, Gurgaon) (Ramayya Hospital, Banglore) (IGICH, Banglore) Dr. Uma Ali Dr. Sachin Shah Dr. Arun Bansal (Wadia Hospital, Mumbai) (Surya Hospital, Pune) (PGl, Chandigarh) International Advisory Board Dr. Mark C. Rogers Dr. Suneel Poobonl Dr. Govlnd BennakattI Dr. Traci Wolbrink (USA) (UK) (NMC Royal Hospital, Abu Dhabi) (Boston Children’s Hospital, USA) Dr. Jerry Zimmerman Dr. Paolo Blban Dr. Phuc H Phan Dr. Sapna Kudchakar (USA) (Italy) (Hanoi,Vietnam) (John Hopkins, USA) Dr. Peter Cox Dr. Swee Phong Tang Dr. Mark Peters Dr. Vijay Srinivasan (Canada) (Kualalampur, Malaysia) (London, UK) (Philadelphia, USA) Dr. Niranjan Kissoon (Vancouver, Canada) National Advisers Dr. Bakul Parekh Dr. Dighant Shastri Dr. Narendra Rungta (Mumbai) (President IAP 2020) (Surat) (President IAP-2019) (JNUIRC, Jaipur) Dr. Piyush Gupta Dr. Pratlbha Singhi (Delhi) (President Elect IAP) (Medanta Hospital, Gurgaon) Executive Members Dr. Rameshkumar R. Dr. Lokesh Tiwari Dr. Sameer Sadawarte (JIPMER, Puduccherry) (AIIMS, Patna) (Fortis Hospital, Mumbai) Dr. Mahammad Ali Dr. Mihir Sarkar Dr. Raghunath CN (Mission Hospital, Durgapur, WB) (PGIPS, Kolkotta) (Sagar Hospital, Banglore) Dr. Raghavendra Vanaki (SNM-HSK Hospital, Bagalkot) Biostatistics Dr. Satyen Gyani Dr. Lalltha A V (Sparsh Hospital, Bhilai) (St. John’s Hospital, Banglore) Ethical Committee Members Dr. M. Jayshree Dr. Preetha Joshi (PGI, Chandigarh) (K. Ambani Hospital, Mumbai) Journal of Pediatric Critical Care | Volume 7 | Issue 5 | September-October 2020 i Indian Academy Of Pediatrics Intensive Care Chapter Excecutive Board 2020 Dr. Basavaraja GV Chairperson Dr. Dhiren Gupta Chairperson Elect Dr. Bakul Parekh Past Chairperson Dr. Dayanand Nakate Vice Chairperson Dr. Arun Bansal Secretary Dr. Manish Sharma Joint Secretary Dr. Vinod Ratagiri Treasurer Dr. Praveen Khilnani Vice Chancellor, IAP-ICC College of Pediatric Critical Care Dr. Kundan Mittal Editor, Journal of Pediatric Critical care South Zone North Zone Dr. K. Rajendran Dr. Punit Pooni Dr. Raghunath CN Dr. Manindar Dhaliwal West Zone Central Zone East Zone Dr. Vinayak Patki Dr. Satyen Gyani Dr. Mihir Sarkar Dr. Sameer Sadawarte Dr. Kasi Bandaru Dr. Sibabratta Patnaik Office: Secretary, IAPICC, R No 3112, Level 3-A, Advanced Pediatric Centre, Post Graduate Institute of Medical Education & Research, Sector 12, Chandigarh – 160 012. ii Journal of Pediatric Critical Care | Volume 7 | Issue 5 | September-October 2020 General Information The journal Copyright Journal of Pediatric Critical Care (ISSN: Print - 2349-6592, The entire contents of the Journal of Pediatric Critical Care Online - 2455-7099) is peer-reviewed journal published on are protected under Indian and international copyrights. behalf of the Intensive Care Chapter of Indian Academy of The Journal, however, grants to all users a free, irrevocable, Pediatrics. Main aim of the journal is to publish research worldwide, perpetual right of access to, and a license to copy, articles,case reports,review articles,editorials related to the use, distribute, perform and display the work publicly and to field of Pediatric critical care and related issues to spread make and distribute derivative works in any digital medium the knowledge amongst pediatricians, intensive care fellows, for any reasonable non-commercial purpose, subject to proper pediatric intensivists, academicians and allied health care attribution of authorship and ownership of the rights. The journal personnel in the field of Pediatric critical care. Articles related also grants the right to make small numbers of printed copies to various subspecialities including (but not limited to) pediatric for their personal non-commercial use. cardiology, pulmonology, nephrology, neurology, infectious diseases, life threatening Pediatric emergencies as well as latest Permissions and emerging technology in diagnosis and therapy of critically For information on how to request permissions to reproduce ill children. The Journal is published Bimonthly in the month of articles/information from this journal, please visit January, March, May, July, September and November. www.jpcc.org.in. Information for Authors Disclaimer There are no page charges for submissions to the journals. The information and opinions presented in the Journal reflect the Please check http://www.jpcc.org.in/contributors.asp for views of the authors and not of the Journal or its Editorial Board details. or the Publisher. Publication does not constitute endorsement by the journal. Neither the Journal of Pediatric Critical Care nor All manuscripts must be submitted online at www.journalonweb. its publishers nor anyone else involved in creating, producing or com/jpcc. delivering the Journal of Pediatric Critical Care or the materials contained therein, assumes any liability or responsibility for Subscription Information the accuracy, completeness, or usefulness of any information Copies of the journal are provided free of cost to the members provided in the Journal of Pediatric Critical Care, nor shall they be of IAPICC. A subscription to Journal of Pediatric Critical Care liable for any direct, indirect, incidental, special, consequential comprises 6 issues. Prices include postage. Annual Subscription or punitive damages arising out of the use of the Journal of Rate for non-members- Pediatric Critical Care. The Journal of Pediatric Critical Care, nor Institutional in India (INR): Rs.15000/- its publishers, nor any other party involved in the preparation For mode of payment and other details, please visit https:// of material contained in the Journal of Pediatric Critical Care www.piccindia.com/pre-application-form-for-jpcc-subscription. represents or warrants that the information contained herein php. is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Readers are encouraged to Claims for missing issues will be serviced at no charge if received confirm the information contained herein with other sources. within 60 days of the cover date for domestic subscribers, and 3 months for subscribers outside India. Duplicate copies cannot Addresses be sent to replace issues not delivered because of failure to Editorial Office notify publisher of change of address. Journal of Pediatric Critical Care, Dr. Vinayak Patki, Nonmembers: Please send change of address information to Chief Pediatric Intensivist and Head, [email protected]
Recommended publications
  • In Partial Fulfilment of Requirements for the Degree Of
    THE EFFECTS OF FEED-BORNE FUSARIUM MYCOTOXINS ON THE PERFORMANCE AND HEALTH OF RAINBOW TROUT (ONCORHYNCHUS MYKISS) A Thesis Presented to The Faculty of Graduate Studies of The University of Guelph by JAMIE MARIE HOOFT In partial fulfilment of requirements for the degree of Master of Science May, 2010 © Jamie M. Hooft, 2010 Library and Archives Bibliothèque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-67487-1 Our file Notre référence ISBN: 978-0-494-67487-1 NOTICE: AVIS: The author has granted a non- L'auteur a accordé une licence non exclusive exclusive license allowing Library and permettant à la Bibliothèque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l'Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans le loan, distribute and sell theses monde, à des fins commerciales ou autres, sur worldwide, for commercial or non- support microforme, papier, électronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriété du droit d'auteur ownership and moral rights in this et des droits moraux qui protège cette thèse. Ni thesis. Neither the thesis nor la thèse ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent être imprimés ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]
  • MCQ-PG Entrance -AGADTANTRA Maitm Ca Maaohyaot \...Mama-B
    BV(DU) COLLEGE OF AYURVED, PUNE-411043 (MH- INDIA) MCQ-PG Entrance -AGADTANTRA 1 maitM ca maaohyaot\...mama-banQaana\ iCnnait ca ÈÈ A) raOxyaat \ B) saaOxmyaat\ tOxNyaat\ AaOYNyaat C) D) 2 ivaYaM ca vaRQdyao …… A) GaRtM B) tOlaM vasaaM xaaOd`M C) D) 3. ……garsaM&M tu ik`yato ivaivaQaaOYaQaOÁ ÈÈ A) kRi~maM B) sqaavarM jaMgamaM dUiYatM C) D) 4. garo…… È A) GaRtM B) tama`M xaaOd`M homaÁ C) D) 5. ….vas~oYau Sayyaasau kvacaaBarNaoYau ca È A) pRYzoYau B) s~xau AnyaoYau padpIzoYau C) D) 6. vaIyaa-lpBaavaanna inapatyaot\ tt\ ……. vaYa-gaNaanaubainQa È A) iptavaR%tM B) vaatavaR%tM kfavaR%tM maodaovaR%tM C) D) 7. According to Sushruta, Sthavar visha adhisthana are …. in number. A) 16 B) 10 C) 8 D) 13 8. According to Sushruta, Jangam visha adhisthana are …. in number. A) 10 B) 12 C) 16 D) 14 Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune. Tel.: 20-24373954; Email- [email protected]; Website:-www.coayurved.bharatividyapeeth.edu 9. …… is one of the ingredients of dooshivishari Agad. A) Mamsi B) Amruta C) Shunthi D) Triphala 10. Which of the following yog is used for the treatment of garopahat pawak? A) Dooshivishari B) Moorvadi C) Eladi D) Panchashirisha 11. Tobacco is……poison. A) Corrosive B) somniferous C) cardiac D) spinal 12. Which of the following is a spinal stimulant poison? A) Ahifen B) Kuchala C) Vatsanabh D) Arka 13. ivaYasaMk`maNaaqa-M mastko BaoYajadanama\ [it……… È A) ]paQaanama \ B) AirYTma\ inaYpIDnama\ pirYaokma\ C) D) 14. Which of the following dravya is not used for hrudayavaran? A) Gomay ras B) Kshaudra C) Supakwa Ekshu D) Mudgayusha 15.
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • CR340 DS69.Indd
    Acta Scientiae Veterinariae, 2018. 46(Suppl 1): 340. CASE REPORT ISSN 1679-9216 Pub. 340 Outbreak of Bovine Herpetic Meningoencephalomyelitis in Southern Brazil Julia Gabriela Wronski1, Bianca Santana Cecco1, Luan Cleber Henker1, Marina Paula Lorenzett1, Paulo Michel Roehe2, Fernando Finoketti2, Thaís Moreira Totti2 & Luciana Sonne1 ABSTRACT Background: Herpetic meningoencephalitis is an infectious contagious disease worldwide distributed, most often caused by bovine alphaherpesvirus type 5 (BoHV-5), although bovine alphaherpesvirus type 1 (BoHV-1) may occasionally be the causative agent. The disease is characterized by subacute to acute clinical onset, often affecting animals submitted to stressful situations. Clinical signs are mainly neurologic due to meningoencephalitis and cortical necrosis. The involve- ment of the spinal cord has also been reported, however in BoHV-1 associated disease only. The aim of this report is to describe an outbreak of bovine meningoencephalomyelitis associated to BoHV-5. Case: In August 2017, nine 1-year-old calves died in a beef cattle farm with a flock of approximately 400 bovines. The animals presented neurological clinical signs characterized by excessive salivation, nasal and ocular discharges, incoor- dination, apathy, head tremors, head pressing, wide-based stance, recumbency followed by convulsions and paddling. According to the owner and referring veterinarian, affected animals displayed severe clinical signs with rapid progression and often leading to death in up to seven days. Four of these
    [Show full text]
  • Cell Injury David S
    91731_ch01 12/1/06 10:10 AM Page 1 1 Cell Injury David S. Strayer Emanuel Rubin Reactions to Persistent Stress and Cell Injury Ionizing Radiation Proteasomes Viral Cytotoxicity Atrophy as Adaptation Chemicals Atrophy as an Active Process Abnormal G Protein Activity Hypertrophy Cell Death Hyperplasia Morphology of Necrosis Metaplasia Necrosis from Exogenous Stress Dysplasia Necrosis from Intracellular Insults Calcification Apoptosis (Programmed Cell Death) Hyaline Initiators of Apoptosis Mechanisms and Morphology of Cell Injury Biological Aging Hydropic Swelling Maximal Life Span Subcellular Changes Functional and Structural Changes Ischemic Cell Injury The Cellular Basis of Aging Oxidative Stress Genetic Factors Nonlethal Mutations that Impair Cell Function Somatic Damage Intracellular Storage Summary Hypothesis of Aging Ischemia/Reperfusion Injury athology is basically the study of structural and functional ab- between its internal milieu and a hostile environment. The normalities that are expressed as diseases of organs and systems. plasma membrane serves this purpose in several ways: PClassic theories of disease attributed disease to imbalances • It maintains a constant internal ionic composition against or noxious effects of humors on specific organs. In the 19th cen- very large chemical gradients between the interior and exte- tury, Rudolf Virchow, often referred to as the father of modern rior compartments. pathology, proposed that injury to the smallest living unit of the body, the cell, is the basis of all disease. To this day, clinical and • It selectively admits some molecules while excluding or ex- experimental pathology remain rooted in this concept. truding others. Teleology—the study of design or purpose in nature—has • It provides a structural envelope to contain the informa- long since been discredited as part of scientific investigation.
    [Show full text]
  • Lacunar Stroke: Mechanisms and Therapeutic Implications
    Cerebrovascular disease J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2021-326308 on 26 May 2021. Downloaded from Review Lacunar stroke: mechanisms and therapeutic implications Shadi Yaghi ,1 Eytan Raz ,2 Dixon Yang,2,3 Shawna Cutting,1 Brian Mac Grory,4 Mitchell SV Elkind,5 Adam de Havenon 6 1Department of Neurology, ABSTRACT overall prevalence of these risk factors is similar Brown University Warren Alpert Lacunar stroke is a marker of cerebral small vessel between lacunar stroke and other stroke subtypes,8 Medical School, Providence, some studies suggest that smoking, hypertension Rhode Island, USA disease and accounts for up to 25% of ischaemic 2Department of Radiology, NYU stroke. In this narrative review, we provide an overview and diabetes are particularly important risk factors Langone Health, New York, New of potential lacunar stroke mechanisms and discuss for lacunar stroke3 7 and that these risk factors may 9 York, USA be more prevalent in patients with lacunar stroke. 3 therapeutic implications based on the underlying Department of Neurology, NYU mechanism. For this paper, we reviewed the literature Among these risk factors, hypertension is most Langone health, New York, New York, USA from important studies (randomised trials, exploratory common in patients with lacunar stroke (68%), 3 7 9 4Department of Neurology, comparative studies and case series) on lacunar stroke followed by diabetes (30%). These studies were Duke Medicine, Durham, North patients with a focus on more recent studies highlighting performed when the control of risk factors, partic- Carolina, USA mechanisms and stroke prevention strategies in ularly hypertension, was less aggressive and more 5Department of Neurology, patients with lacunar stroke.
    [Show full text]
  • CELL INJURY (For First Year Medical Students in 3 Lectures)
    PATHOLOGY Chapter: CELL INJURY (for first year medical students in 3 lectures) [Topics: cell injury, free radical injury, necrosis and apoptosis, cellular accumulations, pathological calcification, adaptation to cell injuries] (lecture 2) DR. SUFIA HUSAIN ASSOCIATE PROF & CONSULTANT DEPARTMENT OF PATHOLOGY COLLEGE OF MEDICINE, KSU, RIYADH. SEPTEMBER 2019 REFERENCE: ROBBINS & COTRAN PATHOLOGY AND RUBIN’S PATHOLOGY Objectives for Cell Injury Chapter (3 lectures) The students should: A. Understand the concept of cells and tissue adaptation to environmental stress including the meaning of hypertrophy, hyperplasia, aplasia, atrophy, hypoplasia and metaplasia with their clinical manifestations. B. Is aware of the concept of hypoxic cell injury and its major causes. C. Understand the definitions and mechanisms of free radical injury. D. Knows the definition of apoptosis, tissue necrosis and its various types with clinical examples. E. Able to differentiate between necrosis and apoptosis. F. Understand the causes of and pathologic changes occurring in fatty change (steatosis), accumulations of exogenous and endogenous pigments (carbon, silica, iron, melanin, bilirubin and lipofuscin). G. Understand the causes of and differences between dystrophic and metastatic calcifications. Lecture 2 outline A. Types of necrosis : Coagulative, Liquefactive, Caseous, gangrenous, fibrinoid and fat necrosis. B. Apoptosis : definition, morphologic features, regulation of apoptosis C. CompArison between necrosis and apoptosis. Normal cell Stress/increased demand Adaptation e.g. hypertrophy Injurious stimuli e.g. hypoxia Unable to adapt Cell injury No more Persistent or injurious stimuli strong injurious stimuli injury is reversible 2 possibilities 1) tissue repair but with diminished capacity à impaired cell function complete repair 2) injury becomes irreversible àcell death (necrosis or apoptosis) Cells/ tissue back to normal Restoration of normal organ function.
    [Show full text]
  • 2014 Slide Library Case Summary Questions & Answers With
    2014 Slide Library Case Summary Questions & Answers with Discussions 51st Annual Meeting November 6-9, 2014 Chicago Hilton & Towers Chicago, Illinois The American Society of Dermatopathology ARTHUR K. BALIN, MD, PhD, FASDP FCAP, FASCP, FACP, FAAD, FACMMSCO, FASDS, FAACS, FASLMS, FRSM, AGSF, FGSA, FACN, FAAA, FNACB, FFRBM, FMMS, FPCP ASDP REFERENCE SLIDE LIBRARY November 2014 Dear Fellows of the American Society of Dermatopathology, The American Society of Dermatopathology would like to invite you to submit slides to the Reference Slide Library. At this time there are over 9300 slides in the library. The collection grew 2% over the past year. This collection continues to grow from member’s generous contributions over the years. The slides are appreciated and are here for you to view at the Sally Balin Medical Center. Below are the directions for submission. Submission requirements for the American Society of Dermatopathology Reference Slide Library: 1. One H & E slide for each case (if available) 2. Site of biopsy 3. Pathologic diagnosis Not required, but additional information to include: 1. Microscopic description of the slide illustrating the salient diagnostic points 2. Clinical history and pertinent laboratory data, if known 3. Specific stain, if helpful 4. Clinical photograph 5. Additional note, reference or comment of teaching value Teaching sets or collections of conditions are especially useful. In addition, infrequently seen conditions are continually desired. Even a single case is helpful. Usually, the written submission requirement can be fulfilled by enclosing a copy of the pathology report prepared for diagnosis of the submitted case. As a guideline, please contribute conditions seen with a frequency of less than 1 in 100 specimens.
    [Show full text]
  • Cutaneous Chemical Burns: Assessment and Early Management
    CLINICAL Cutaneous chemical burns: assessment and early management Neiraja Gnaneswaran, Eshini Perera, Marlon Perera, Raja Sawhney Background urns are a common trauma that affects up to 1% of the Australian population and may be associated with Chemical burns are common and may cause significant B significant physical, psychological, social and economic physical, psychological, social and economic burden. Despite burden.1 Chemical burns represents 3–5% of all burns-associated a wide variety of potentially harmful chemicals, important admissions.2 Despite the small proportion, chemical burns general principals may be drawn in the assessment and initial account for 30% of burns-associated death,3,4 most commonly management of such injuries. Early treatment of chemical burns occurring as a result of chemical ingestion. Given the nature is crucial and may reduce the period of resulting morbidity. of injury, hospitalisation tends to be prolonged and healing is Objective delayed. Many substances that are freely available in the community, This article reviews the assessment and management of either occupational or domestic items, have the potential to cause cutaneous chemical burns. chemical burns. The immediate availability and poor labelling of these substances has accounted for an increase in unintentional Discussion chemical burns. Assault and suicidal attempts account for the remaining cases of chemical burns. The affected population is Assessment of the patient should be rapid and occur in conjunction with early emergency management. Rapid history generally evenly distributed but an increase in paediatric chemical 5 and primary and secondary survey may be required to exclude burns has been previously documented. Areas affected tend systemic side effects of the injury.
    [Show full text]
  • Cell Injury, Adaptation, and Death
    CHAPTER 2 Cell Injury, Adaptation, and Death This chapter discusses the natural and pathologic life and death of cells and how they change with disease, covering biologic aging as well as distinguishing between mild and severe cell injury. BACK TO BASICS BIOLOGIC AGING • The Origins of Cells and the Organization of Tissues CELL INJURY AND DISEASE • The Nucleus MILD CELL INJURY • The Cytoplasm • Intracellular Accumulations • The Cell Membrane • Adaptations of Cell Growth and Differentiation • The Cell Cycle SEVERE CELL INJURY AND CELL DEATH • Cellular Communication Learning Objectives After studying this chapter you should be able to: 1. Offer a brief description of the basic organization of a cell and of the organization of tissues, organs, and organ systems 2. Explain how the genetic code is written into DNA 3. Explain the role of messenger RNA 4. Explain the role of mitochondria 5. Explain how DNA replicates during cell division (mitosis) 6. Differentiate between apoptosis and necrosis 7. Explain the relationship between injury and disease 8. Explain the relationship of genes and environment in the pathogenesis of disease 9. Name the most common cause of cell injury 10. Name one cell reaction resulting from mild acute cell injury and one resulting from mild chronic injury 11. List at least two causes of cell atrophy 12. Differentiate between hypertrophy and hyperplasia 13. Define dysplasia 14. Define metaplasia and offer an example 15. Name the consequence of severe, irreversible cell injury 16. Name the most common cause of necrosis
    [Show full text]
  • Radiation Induced Temporal Lobe Necrosis in Patients With
    Chen et al. Radiation Oncology 2011, 6:128 http://www.ro-journal.com/content/6/1/128 REVIEW Open Access Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management Jing Chen1†, Meera Dassarath1,2†, Zhongyuan Yin1, Hongli Liu1, Kunyu Yang1* and Gang Wu1 Abstract Temporal lobe necrosis (TLN) is the most debilitating late-stage complication after radiation therapy in patients with nasopharyngeal cancer (NPC). The bilateral temporal lobes are inevitably encompassed in the radiation field and are thus prone to radiation induced necrosis. The wide use of 3D conformal and intensity-modulated radiation therapy (IMRT) in the treatment of NPC has led to a dwindling incidence of TLN. Yet, it still holds great significance due to its incapacitating feature and the difficulties faced clinically and radiologically in distinguishing it from a malignancy. In this review, we highlight the evolution of different imaging modalities and therapeutic options. FDG PET, SPECT and Magnetic Spectroscopy are among the latest imaging tools that have been considered. In terms of treatment, Bevacizumab remains the latest promising breakthrough due to its ability to reverse the pathogenesis unlike conventional treatment options including large doses of steroids, anticoagulants, vitamins, hyperbaric oxygen and surgery. Keywords: Nasopharyngeal cancer, radiation therapy, temporal lobe necrosis, Bevacizumab Introduction treated with conventional 2D radiotherapy rather than Nasopharyngeal cancer (NPC) is highly prevalent in 3D or IMRT. An incidence of TLN of 4.6% in 10 years Southern China, particularly in Guangdong province and (conventional fractionation) [4] to 35% in 3.5 years in the northern parts of Africa and Inuits of Alaska [1].
    [Show full text]